GSA CAPITAL PARTNERS LLP
Follow13F filer, CIK 1362033, LONDON, United Kingdom
GSA CAPITAL PARTNERS LLP reported $1,427,945,000 across 1,695 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-07-22. Its ten largest share positions make up 6.36% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001362033-25-000007
- Period
- 2025-06-30
- Reported value
- $1.43B
- Holdings
- 1,695
- Top 10 weight
- 6.36%
- New
- 649
- Sold out
- 550
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| NVDAadded | +101,230 | $16M |
| AAPLadded | +66,405 | $13.6M |
| MSFTadded | +26,073 | $13M |
| BRK-Bnew | +16,625 | $8.08M |
| JPMadded | +25,589 | $7.42M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CSXreduced | -137,015 | -$4.47M |
| BXreduced | -29,051 | -$4.34M |
| WK KELLOGG COexited | -160,791 | -$3.21M |
| CALMexited | -32,080 | -$2.92M |
| NVTreduced | -36,705 | -$2.69M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Back to all 1,695 share positions
Sold out in Q2 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| XIFRXPLR INFRASTRUCTURE LP | 10,369 | $99K | shares |
| MATVMATIV HOLDINGS INC | 15,718 | $98K | shares |
| DDD3D SYS CORP DEL | 46,019 | $98K | shares |
| DHXDHI GROUP INC | 68,826 | $96K | shares |
| HBIOHARVARD BIOSCIENCE INC | 168,444 | $95K | shares |
| SGMTSAGIMET BIOSCIENCES INC | 28,930 | $94K | shares |
| MBXMBX BIOSCIENCES INC | 12,369 | $91K | shares |
| ASPNASPEN AEROGELS INC | 14,294 | $91K | shares |
| ORICORIC PHARMACEUTICALS INC | 15,844 | $88K | shares |
| CURVTORRID HLDGS INC | 15,229 | $83K | shares |
| FTEKFUEL TECH INC | 79,247 | $83K | shares |
| INOZYME PHARMA INCINOZYME PHARMA INC | 89,651 | $82K | shares |
| BCABBIOATLA INC | 233,156 | $81K | shares |
| GALTGALECTIN THERAPEUTICS INC | 66,396 | $81K | shares |
| GSMFERROGLOBE PLC | 20,395 | $76K | shares |
| PIXELWORKS INCPIXELWORKS INC | 119,480 | $75K | shares |
| GROBRAZIL POTASH CORP | 21,751 | $67K | shares |
| LOANMANHATTAN BRDG CAP INC | 10,511 | $62K | shares |
| INTEVAC INCINTEVAC INC | 15,281 | $61K | shares |
| TCRXTSCAN THERAPEUTICS INC | 41,817 | $58K | shares |
| CTSOCYTOSORBENTS CORP | 53,030 | $53K | shares |
| CVVCVD EQUIP CORP | 17,347 | $53K | shares |
| GTECGREENLAND TECHNOLOGIES HLDG | 25,916 | $45K | shares |
| SYSTEM1 INCSYSTEM1 INC | 118,709 | $45K | shares |
| XGNEXAGEN INC | 12,287 | $44K | shares |
| TOURTUNIU CORP | 40,123 | $44K | shares |
| LWLGLIGHTWAVE LOGIC INC | 39,842 | $41K | shares |
| BWBABCOCK & WILCOX ENTERPRISES | 59,112 | $40K | shares |
| LFTLUMENT FINANCE TRUST INC | 14,329 | $37K | shares |
| EQCEQUITY COMMONWEALTH | 21,467 | $35K | shares |
| STLNSTARLING ONCOLOGY INC | 28,529 | $33K | shares |
| LAESSEALSQ CORP | 11,948 | $31K | shares |
| OSSONE STOP SYS INC | 13,127 | $30K | shares |
| ZURAZURA BIO LTD | 22,702 | $29K | shares |
| KAIXIN HLDGSKAIXIN HLDGS | 31,039 | $29K | shares |
| PVLPERMIANVILLE RTY TR | 17,570 | $27K | shares |
| TUSKMAMMOTH ENERGY SVCS INC | 12,029 | $25K | shares |
| WRAPWRAP TECHNOLOGIES INC | 14,545 | $25K | shares |
| ATHIRA PHARMA INCATHIRA PHARMA INC | 88,233 | $25K | shares |
| CMPXCOMPASS THERAPEUTICS INC | 12,187 | $23K | shares |
| ANNXANNEXON INC | 11,425 | $22K | shares |
| E2OPEN PARENT HOLDINGS INCE2OPEN PARENT HOLDINGS INC | 10,594 | $21K | shares |
| PRQRPROQR THRAPEUTICS N V | 14,683 | $20K | shares |
| CHGGCHEGG INC | 27,641 | $18K | shares |
| AFMDQAFFIMED N V ORDINARY SHARES NE | 15,895 | $11K | shares |
| CGTXCOGNITION THERAPEUTICS INC | 22,354 | $9K | shares |
| VOR BIOPHARMA INCVOR BIOPHARMA INC | 11,859 | $9K | shares |
| CHRSCOHERUS ONCOLOGY INC | 10,153 | $8K | shares |
| Veru IncVeru Inc | 14,978 | $7K | shares |
| CBDMD INCCBDMD INC | 31,758 | $7K | shares |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001362033-25-000007 | base | 2025-07-22 | acceptance time not in the bulk data set |